期刊文献+

奈达铂联合氟尿嘧啶治疗初治鼻咽癌24例近期疗效观察 被引量:7

下载PDF
导出
摘要 目的:观察奈达铂联合氟尿嘧啶治疗24例初治鼻咽癌近期疗效和不良反应。方法:24例初治鼻咽癌患者接受奈达铂及氟尿嘧啶方案化疗,奈达铂80mg/m2静脉滴注,d1;5-FU2.5g/m2连续静脉滴注46h。治疗2个周期后按WHO实体瘤疗效评定标准评价疗效及毒副反应。结果:全组24例均可评价疗效,总有效率79.2%(19/24),主要不良反应为Ⅲ~Ⅳ度骨髓抑制及消化道症状。结论:奈达铂联合氟尿嘧啶治疗初治鼻咽癌近期疗效好,不良反应较轻,多数患者能耐受,是治疗鼻咽癌的较好方案。
作者 王林江
出处 《实用中西医结合临床》 2011年第3期55-56,共2页 Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献6

  • 1Baujat B,Audry H,Bourhis J,et al.Chemotherapy in locally advanced nasopharyngeal carcinoma:an individual patient datameta-analysis ofeightrandomized trials and 1 753 patients[J].lnt J Radial Oncol Biol Phys,2006,64(1):47-56. 被引量:1
  • 2Kawashima M,Fuwa N,Myojin M,et al.A multi-institutional survey of the effectiveness of chemotherapy combined with radio-therapy for patients with nasopharyngeal carcinoma[J].Jpn J Clin Oncol,2004,34(10):569-583. 被引量:1
  • 3Desoize B,Madoulet C.Particular aspects of platinum compounds used a present in cancer treatment[J].Crit Rev Oncol Hemato,2002,42(3):317-325. 被引量:1
  • 4徐瑞华,管忠震,姜文奇,黄河,胡晓桦,谢伟敏,李星庚,刘亚利,潘良熹,戴爱娣,庄武,张春,马智勇,王建华.奈达铂治疗非小细胞肺癌的Ⅱ期临床研究报告[J].癌症,2002,21(12):1354-1358. 被引量:132
  • 5Ota KNedaplatin[J].Gan To Kajaku Ryoho,1996,23(3):379-387. 被引量:1
  • 6张力,姜文奇,徐瑞华,管忠震.紫杉醇(Paclitaxel)治疗晚期鼻咽癌的临床研究[J].癌症,2000,19(8):811-813. 被引量:58

二级参考文献10

  • 1Taguchi T, Wakui A, Nabeya K, et al. A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group [J]. Gan To Kagaku Ryoho, 1992,19(4):483-488. 被引量:1
  • 2Inuyama Y, Miyake H, Horiuchi M, et al. A late phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers [J]. Gan To Kagaku Ryoho, 1992,19(6): 871-877. 被引量:1
  • 3Le Chevalier T, Brisgand D, Douillard JY, et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients[J]. J Clin Oncol, 1994,12:360-367. 被引量:1
  • 4Furuse K, Fukuoka M, Asamoto H, et al. A randomized comparative study of 254-S plus vindesine(VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC) [J]. Gan To Kagaku Ryoho,1992,19(7):1019-1026. 被引量:1
  • 5Fukuda M, Shinkai T, Eguchi K, et al. Phase II study of (glycolate-O,O′ ) diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancer [J]. Cancer Chemother Pharmacol,1990,26(6):393-396. 被引量:1
  • 6Yoshioka T, Gamoh M, Shineha R, et al. A new combination chemotherapy with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for advanced esophageal cancers [J]. Intern Med, 1999, 38(11): 844-848. 被引量:1
  • 7徐瑞华,管忠震.硫酸长春地辛Ⅲ期临床试验总结[J].癌症,1998,17(3):197-200. 被引量:32
  • 8徐瑞华,姜文奇,刘冬耕,滕小玉,管忠震.VIP与MVP方案治疗非小细胞肺癌的对照研究[J].癌症,1999,18(6):711-713. 被引量:12
  • 9张力,管忠震.诱导化疗在鼻咽癌治疗中的作用[J].癌症,1992,11(3):234-238. 被引量:10
  • 10吡喃阿霉素临床验证协作组.吡喃阿霉素(THP—ADR)与阿霉素治疗恶性肿瘤的临床对照观察[J].癌症,1993,12(6):518-521. 被引量:34

共引文献187

同被引文献40

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部